To assess whether KAP1 was a downstream effector of MYCN, we knocked out MYCN using two different sgRNAs, sgMYCN#1 and sgMYCN#2 in SK-N-BE(2) NB cells with MYCN amplification. Here, MYCN is linked to neuroblastoma.